Image 5_G. vaginalis increases HSV-2 infection by decreasing vaginal barrier integrity and increasing inflammation in vivo.tif by Nuzhat Rahman (16660416)

“…</p>Results<p>G. vaginalis inoculated mice infected with HSV-2 had significantly decreased survival rates, increased pathology, and higher viral titers than PBS and L. crispatus inoculated mice. …”

Image 3_G. vaginalis increases HSV-2 infection by decreasing vaginal barrier integrity and increasing inflammation in vivo.tif by Nuzhat Rahman (16660416)

“…</p>Results<p>G. vaginalis inoculated mice infected with HSV-2 had significantly decreased survival rates, increased pathology, and higher viral titers than PBS and L. crispatus inoculated mice. …”

Image 1_G. vaginalis increases HSV-2 infection by decreasing vaginal barrier integrity and increasing inflammation in vivo.tif by Nuzhat Rahman (16660416)

“…</p>Results<p>G. vaginalis inoculated mice infected with HSV-2 had significantly decreased survival rates, increased pathology, and higher viral titers than PBS and L. crispatus inoculated mice. …”

Image 4_G. vaginalis increases HSV-2 infection by decreasing vaginal barrier integrity and increasing inflammation in vivo.tif by Nuzhat Rahman (16660416)

“…</p>Results<p>G. vaginalis inoculated mice infected with HSV-2 had significantly decreased survival rates, increased pathology, and higher viral titers than PBS and L. crispatus inoculated mice. …”

Number of visits per clinic type, 2013-2015. by Jacob Dreiher (14856863)

“…During PE, statistically significant longer waiting times were found for surgery (+1.0 day) and imaging (+1.1 days), while a 2.4 days decrease was noted in pediatrics, controlled for age, sex, ethnicity and the daily number of visits. …”

<i>In vivo</i> treatment decreases bacterial burden and colonization of vital organs in a skin abscess biofilm infection model. by Robert L. Beckman I.V (22784303)

Map of Zimbabwe highlighting the districts detected as persistent hotspots of <i>S. haematobium</i> prevalence (PPHS), persistent hotspots of decreased praziquantel efficacy (EPHS)... by Takafira Mduluza (39754)

<i>In vitro</i> characterization of the mnuA::Tn and 0690::Tn mutants. by Aga E. Gelgie (17661720)

Subjects:

Impact of 5′ nucleotidase disruption on <i>M</i>. <i>bovis</i> growth phenotype in axenic conditions. by Aga E. Gelgie (17661720)

Subjects:

Open data. by Larissa Brazolotto Ferreira (17671168)

Subjects:

Schematic representation of the studied populations at the time of study sampling. by Maria Raffaella Petrara (4446358)

Subjects:

Variations of shear strength with curing time and normal stress. by Hao Yu (157186)

Subjects:

Measurement of the patients’ dental cast models. by Miki Kashiwagi (21439684)

Subjects:

Characteristics of HACE respondents by year. by David Henderson (4612354)

Subjects:

Results obtained from different regression models along with their respective AIC values. by Farzana Afroz (20700794)

Subjects:

Descriptive statistics for the number of under five children death per 100 mothers. by Farzana Afroz (20700794)

Subjects:

Histogram for the number of under five children death per mother. by Farzana Afroz (20700794)

Subjects:

Comparison of step rate, step length, stance time, and flight time between tasks in eight intervals from the start to the 40 m mark. by Shinnosuke Hase (20917896)

Velar adhesion (VA). by Miki Kashiwagi (21439684)

Subjects:

Mean standard errors across time points for the outcome of social stigma. by Ana Beato (20489933)

Subjects: